Prevention of CKD in patients with Hypertension.pdf
Prevention of CKD in patients with Hypertension.pdf Prevention of CKD in patients with Hypertension.pdf
Figure 1. Average net change in systolic BP (left) and diastolic BP (right) and corresponding 95% CIs related toalcohol reduction intervention in 15 randomized controlled trials. Net change was calculated as the difference of thebaseline minus follow-up levels of BP for the intervention and control groups (parallel trials) or the difference in BPlevels at the end of the intervention and control treatment periods (crossover trials). The overall effect represents apooled estimate obtained by summing the average net change for each trial, weighted by the inverse of its variance.Data on diastolic BP were not available in 1 trial.1
- Page 1 and 2: PreventionofChronic Kidney Diseasei
- Page 3 and 4: What will I cover?• Definition of
- Page 5 and 6: Definition of hypertension
- Page 7: Patient evaluation(1) Identifiable
- Page 10 and 11: Treatments in hypertensive patients
- Page 20 and 21: Lifestyle modification
- Page 22 and 23: AAntihypertensive drugs
- Page 24 and 25: CAntihypertensive drugs
- Page 26 and 27: OAntihypertensive drugs
- Page 28: Major outcomes in high-risk hyperte
- Page 32: Benefit of blood pressure control
- Page 36 and 37: Secondary causes of progressionin C
- Page 44: Antihypertensive drugs withcompelli
- Page 51 and 52: Conclusion• Treatments in hyperte
Figure 1. Average net change <strong>in</strong> systolic BP (left) and diastolic BP (right) and correspond<strong>in</strong>g 95% CIs related toalcohol reduction <strong>in</strong>tervention <strong>in</strong> 15 randomized controlled trials. Net change was calculated as the difference <strong>of</strong> thebasel<strong>in</strong>e m<strong>in</strong>us follow-up levels <strong>of</strong> BP for the <strong>in</strong>tervention and control groups (parallel trials) or the difference <strong>in</strong> BPlevels at the end <strong>of</strong> the <strong>in</strong>tervention and control treatment periods (crossover trials). The overall effect represents apooled estimate obta<strong>in</strong>ed by summ<strong>in</strong>g the average net change for each trial, weighted by the <strong>in</strong>verse <strong>of</strong> its variance.Data on diastolic BP were not available <strong>in</strong> 1 trial.1
Change language